Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial

Published:2021 Issue:1 Volume:33 Page:53-60
ISSN:1000-9604
Container-title:Chinese Journal of Cancer Research
language:en
Short-container-title:

Author:

Yang Xu, ,Zhai Yirui,Bi Nan,Zhang Tao,Deng Lei,Wang Wenqing,Wang Xin,Chen Dongfu,Zhou Zongmei,Wang Luhua,Liang Jun

Publisher

Chinese Journal of Cancer Research

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert consensus on radiotherapy for elderly patients with esophageal cancer in China (2024 edition);Radiation Medicine and Protection;2024-07

2. Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial;BMC Cancer;2024-06-04

3. Research Progress in Targeted Therapy for Esophageal Cancer;Journal of Biosciences and Medicines;2024

4. Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study;Current Cancer Drug Targets;2023-09

5. Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies;Onco;2023-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP